GLPro uses ingredients that are generally safe for long-term use at recommended doses, but no supplement is risk-free
Chun JH, Butts A (2020) Long-acting GLP-1RAs: an overview of efficacy, safety, and their role in type 2 diabetes management
Together, well discuss: How the latest obesity medications are reshaping clinical care Why understanding the biology of obesity is essential to improving outcomes The critical role of lifestyle medicine alongside emerging treatments How personalized care and compassion can help reduce weight bias and improve long-term health What the lived experiences of people with obesity teach us about creating more effective, patient-centered care Whether youre a healthcare professional, someone living with obesity, or simply interested in the future of medicine, this conversation will provide evidence-based insights, practical perspectives, and an inspiring vision for the future of obesity care
For a personalised assessment based on your health profile, GERD status, and goals, we recommend consulting with a qualified bariatric team who can provide transparent information about expected outcomes, costs, and aftercare requirements.
Men in the highest tirzepatide dose group lost an average of 22.5% of their starting weight, with cardiovascular risk markers improving significantly including reductions in blood pressure, triglycerides, and inflammatory markers
